HOPPEN develops technological tools and solutions intended to support hospitals and clinics in their digital transformation, providing concrete responses to... View Article
Author Archives for Adeline Chauvigné
New member | Hoppen
27 February 2026HOPPEN develops technological tools and solutions intended to support hospitals and clinics in their digital transformation, providing concrete responses to... View Article
Owkin Closes Series A Round to Deploy Federated Learning for Research at Scale, with a Total of $70M Raised
Series A round closed with an $18 million commitment from Mubadala Investment Company’s asset management arm, Mubadala Capital in... View Article
Owkin Closes Series A Round to Deploy Federated Learning for Research at Scale, with a Total of $70M Raised
27 February 2026Series A round closed with an $18 million commitment from Mubadala Investment Company’s asset management arm, Mubadala Capital in... View Article
The CE4BIG project: A European project federating four major clusters in the healthcare sector
The French Atlanpole Biotherapies in Nantes is federating four major healthcare clusters aimed at fostering business growth in SMEs specialising... View Article
The CE4BIG project: A European project federating four major clusters in the healthcare sector
27 February 2026The French Atlanpole Biotherapies in Nantes is federating four major healthcare clusters aimed at fostering business growth in SMEs specialising... View Article
XENOTHERA secures funding of its anti-Covid treatment, and accelerates its product portfolio by a total amount of more than 7 million euros
XENOTHERA, a Nantes-based biotech created in 2014, today announced that it has been awarded 2.3 million euros by the French Government,... View Article
XENOTHERA secures funding of its anti-Covid treatment, and accelerates its product portfolio by a total amount of more than 7 million euros
27 February 2026XENOTHERA, a Nantes-based biotech created in 2014, today announced that it has been awarded 2.3 million euros by the French Government,... View Article
i-SEP has obtained authorisations from ANSM and AFMPS to launch its clinical trial in France and Belgium
I-SEP, a French MedTech (Nantes) specialising in blood processing and Patient Blood Management, has developed and patented a pioneering technology... View Article
i-SEP has obtained authorisations from ANSM and AFMPS to launch its clinical trial in France and Belgium
27 February 2026I-SEP, a French MedTech (Nantes) specialising in blood processing and Patient Blood Management, has developed and patented a pioneering technology... View Article
#Coronavirus | Biofortis: providing virological and serological diagnostic tests
Biofortis, a clinical research organisation specialized in nutrition and microbiota analysis, has taken all the necessary steps regarding the health... View Article
#Coronavirus | Biofortis: providing virological and serological diagnostic tests
27 February 2026Biofortis, a clinical research organisation specialized in nutrition and microbiota analysis, has taken all the necessary steps regarding the health... View Article
GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicines Agency (EMA)
GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicines Agency (EMA) on its Clinical Development and Biomanufacturing Strategy... View Article
GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicines Agency (EMA)
27 February 2026GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicines Agency (EMA) on its Clinical Development and Biomanufacturing Strategy... View Article
#Coronavirus | AtlanChim Pharma: special offer on fine Organic chemistry supporting Covid-19 Research
📣 In these extraordinary circumstances ATLANCHIM PHARMA wishes to collaborate with developers of small molecules based COVID-19 #covid #chemistry For your request... View Article
#Coronavirus | AtlanChim Pharma: special offer on fine Organic chemistry supporting Covid-19 Research
27 February 2026📣 In these extraordinary circumstances ATLANCHIM PHARMA wishes to collaborate with developers of small molecules based COVID-19 #covid #chemistry For your request... View Article
New member | Odaxos
Founded in 2008 in Mayenne (France), Odaxos designs, develops and markets dental devices (dental occlusion). Since 2018, the company... View Article
New member | Odaxos
27 February 2026Founded in 2008 in Mayenne (France), Odaxos designs, develops and markets dental devices (dental occlusion). Since 2018, the company... View Article
New member – Vetbiobank
Vetbiobank is a veterinary french biotech specialized since 2011 in the development and manufacturing of innovative animal cell-based drugs for... View Article
New member – Vetbiobank
27 February 2026Vetbiobank is a veterinary french biotech specialized since 2011 in the development and manufacturing of innovative animal cell-based drugs for... View Article